Motivation Skills Training for Serious Mental Illness
(MST Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications since the trial focuses on motivation skills training and not on medication changes.
What data supports the effectiveness of the treatment Motivation Skills Training for Serious Mental Illness?
Is Motivation Skills Training safe for people with serious mental illness?
How is Motivation Skills Training (MST) different from other treatments for serious mental illness?
Motivation Skills Training (MST) is unique because it focuses on enhancing both intrinsic (internal) and extrinsic (external) motivation to improve treatment engagement and outcomes, particularly in individuals with schizophrenia who often experience motivational impairments. This approach is distinct from other treatments as it directly targets motivation to facilitate learning and skill acquisition, which is crucial for improving psychosocial functioning.12469
What is the purpose of this trial?
This study will take place at four outpatient clinics serving adults with serious mental illness. Informed consent will be obtained from N=80 individuals with a Diagnostic and Statistical Manual of Mental Illnesses (DSM)-5 diagnosis of schizophrenia or schizoaffective disorder meeting inclusion/exclusion criteria to participate in a randomized controlled trial comparing Motivation Skills Training (MST) to a Healthy Behaviors Control (HBC) group. Eligible participants will receive a baseline assessment including sociodemographic and psychosocial assessments, measures of motivation, goal attainment, and quality of life, as well as measures of executive skills, community functioning, and psychiatric symptoms severity. Both MST and HBC will be implemented as once weekly group therapies. The treatment phase is approximately 12-14 weeks. MST will focus on motivation knowledge and self-regulation skills while HBC will focus on physical health and health-related skills.
Research Team
Alice Saperstein, PhD
Principal Investigator
Columbia University
Eligibility Criteria
Adults aged 18-65 with schizophrenia or schizoaffective disorder, who speak English and are stable enough to attend outpatient therapy. They shouldn't have intellectual disabilities (IQ <70), severe recent substance use, or brain diseases due to neurological conditions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessments including sociodemographic and psychosocial assessments, measures of motivation, goal attainment, and quality of life, as well as measures of executive skills, community functioning, and psychiatric symptoms severity
Treatment
Participants receive weekly group-based interventions, either Motivation Skills Training (MST) or Healthy Behaviors Control (HBC), focusing on motivation and self-regulation skills or physical health and health-related skills, respectively
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments of functional outcomes, motivation, and quality of life
Treatment Details
Interventions
- Healthy Behaviors Control Group
- Motivation Skills Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator